Cortical myoclonus in childhood and juvenile onset Huntington's disease

Parkinsonism and Related Disorders

Volumn 18, Issue 6, 2012, Pages 794-797

  Rossi Sebastiano, Davide ^a   Soliveri, Paola ^a   Panzica, Ferruccio ^a   Moroni, Isabella ^a   Gellera, Cinzia ^a   Gilioli, Isabella ^a   Nardocci, Nardo ^a   Ciano, Claudia ^a   Albanese, Alberto ^a   Franceschetti, Silvana ^a   Canafoglia, Laura ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Coherence analysis; Juvenile huntington disease; Myoclonus; Progressive myoclonus epilepsy

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHILD; CHILDHOOD ONSET HUNTINGTON CHOREA; CONTROLLED STUDY; CORTICAL MYOCLONUS; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; EVOKED SOMATOSENSORY RESPONSE; HUMAN; HUNTINGTON CHOREA; JERK LOCKED BACK AVERAGING; JUVENILE ONSET HUNTINGTON CHOREA; LONG LOOP REFLEX; MUSCLE CONTRACTION; MYOCLONUS; NERVOUS SYSTEM PARAMETERS; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHILD; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; HUNTINGTON DISEASE; MYOCLONUS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84862224325     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.03.011     Document Type: Article

References (12)

1. Nance M.A., Myers R.H. Juvenile onset Huntington's disease - clinical and research perspectives. Ment Retard Dev Disabil Res Rev 2001, 7:153-157.
2. Thompson P.D., Bhatia K.P., Brown P., Davis M.B., Pires M., Quinn N.P., et al. Cortical myoclonus in Huntington's disease. Mov Disord 1994, 9:633-641.
3. Siesling S., Vegter-van der Vlis M., Roos R.A. Juvenile Huntington disease in the Netherlands. Pediatr Neurol 1997, 17:37-43.
4. Gambardella A., Muglia M., Labate A., Magariello A., Gabriele A.L., Mazzei R., et al. Juvenile Huntington's disease presenting as progressive myoclonic epilepsy. Neurology 2001, 57:708-711.
5. Caviness J.N., Kurth M. Cortical myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential. Mov Disord 1997, 12:1046-1051.
6. Adam O.R., Jankovic J. Symptomatic treatment of Huntington disease. Neurotherapeutics 2008, 5:181-197.
7. Panzica F., Canafoglia L., Franceschetti S., Binelli S., Ciano C., Visani E., et al. Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models. Clin Neurophysiol 2003, 114:1041-1052.
8. Canafoglia L., Ciano C., Panzica F., Scaioli V., Zucca C., Agazzi P., et al. Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease. Neurology 2004, 63:2309-2315.
9. Reynolds N.C., Prost R.W., Mark L.P., Joseph S.A. MR-spectroscopic findings in juvenile-onset Huntington' s disease. Mov Disord 2008, 23:1931-1935.
10. Cummings D.M., André V.M., Uzgil B.O., Gee S.M., Fisher Y.E., Cepeda C., et al. Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease. J Neurosci 2009, 29:10371-10386.
11. Reis J., Tergau F., Hamer H.M., Müller H.H., Knake S., Fritsch B., et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 2002, 43:1149-1156.
12. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J Clin Neurophysiol 2002, 19:272-293.